What is the recommended treatment for typhoid fever in pediatric patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Typhoid Fever in Pediatric Patients

The recommended first-line treatment for typhoid fever in pediatric patients is azithromycin at 20 mg/kg/day (maximum 1g/day) orally for 7 days, especially in areas with high fluoroquinolone resistance. 1

First-Line Treatment Options

  • Azithromycin 20 mg/kg/day (maximum 1g/day) orally for 7 days is recommended as first-line therapy, with a documented 94% cure rate in children and lower risk of relapse compared to ceftriaxone 1
  • For severe cases requiring hospitalization, ceftriaxone 50-80 mg/kg/day (maximum 2g/day) intravenously for 5-7 days is recommended 1, 2
  • A 5-day course of azithromycin has been shown to be effective for uncomplicated typhoid fever in children and adolescents with a 94% cure rate 3

Treatment Based on Resistance Patterns

  • For fully susceptible S. typhi strains (increasingly rare), fluoroquinolones may be considered, though resistance is becoming common globally 1
  • For multidrug-resistant strains: fluoroquinolone (if susceptible) or cefixime, with azithromycin as an alternative 4
  • For quinolone-resistant strains (>70% of isolates in many regions): azithromycin or ceftriaxone is recommended as first-line therapy 4, 1

Specific Antibiotic Regimens

Azithromycin

  • Dosing: 20 mg/kg/day (maximum 1g/day) orally for 7 days 1
  • Benefits: Lower relapse rates compared to ceftriaxone (OR 0.09) 4
  • No relapses were observed in a study comparing azithromycin to ceftriaxone in children 3

Ceftriaxone

  • Dosing: 50-80 mg/kg/day (maximum 2g/day) IV/IM for 5-7 days 5, 2
  • A flexible-duration approach (continuing until defervescence plus 5 additional days) has shown good results with no relapses 6
  • Mean defervescence time with ceftriaxone is approximately 5.4 days 6

Cefixime

  • Dosing: 10 mg/kg/day divided every 12 hours for 14 days 7
  • Can be as effective as parenteral ceftriaxone for uncomplicated cases 7
  • Time to defervescence is comparable to ceftriaxone (approximately 8 days) 7

Ciprofloxacin (only if susceptibility confirmed)

  • Dosing: 15 mg/kg twice daily for 7-10 days 5
  • Should be avoided empirically in cases originating from South Asia due to high resistance rates 1
  • For severe cases, initial IV dosing at 10 mg/kg/day has shown 94.4% efficacy in children 8

Treatment Algorithm

  1. For uncomplicated typhoid fever:

    • First choice: Azithromycin 20 mg/kg/day (maximum 1g/day) orally for 7 days 1
    • Alternative: Cefixime 10 mg/kg/day divided every 12 hours for 14 days (if azithromycin unavailable) 7
  2. For severe cases requiring hospitalization:

    • First choice: Ceftriaxone 50-80 mg/kg/day IV for 5-7 days 5, 2
    • Consider transition to oral therapy once clinical improvement occurs 2
    • Alternative approach: Continue ceftriaxone until defervescence plus 5 additional days 6
  3. For multidrug-resistant typhoid with confirmed susceptibility:

    • Consider ciprofloxacin 15 mg/kg twice daily for 7-10 days only if susceptibility is confirmed 5, 1

Important Clinical Considerations

  • Always obtain blood cultures before starting antibiotics when possible, as they have the highest yield within the first week of symptom onset 4, 2
  • Monitor for clinical response, with expected fever clearance within 4-5 days of appropriate therapy 1
  • Complications of typhoid fever (gastrointestinal bleeding, intestinal perforation, typhoid encephalopathy) occur in 10-15% of patients and are more likely if duration of illness exceeds 2 weeks 4
  • Resistance to fluoroquinolones is essentially a class effect and is increasing globally, making them less reliable as empiric therapy 1

Common Pitfalls to Avoid

  • Avoid using ciprofloxacin empirically for cases originating from South Asia due to high resistance rates 1
  • Do not rely solely on clinical presentation for diagnosis; obtain cultures whenever possible 1
  • Consider local resistance patterns when selecting empiric therapy, as these vary geographically and change over time 1
  • Be aware that vaccination provides incomplete protection against typhoid fever and does not protect against paratyphoid 4

References

Guideline

Treatment of Enteric Fever in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Ceftriaxone Treatment for Typhoid Fever

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Short-course azithromycin for the treatment of uncomplicated typhoid fever in children and adolescents.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004

Guideline

Azithromycin for Typhoid Fever Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Ciprofloxacin for treatment of severe typhoid fever in children.

Antimicrobial agents and chemotherapy, 1993

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.